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Loeys-Dietz syndrome (LDS) is a connective tissue disorder characterized by vascular findings of aneurysm and/or dissection of
cerebral, thoracic, or abdominal arteries and skeletal findings. We report a case of a novel pathogenic variant in TGFBR2 and
phenotype consistent with classic LDS.The proband was a 10-year-old presenting to the genetics clinic with an enlarged aortic root
(Z-scores 5-6), pectus excavatum, and congenital contractures of the right 2nd and 3rd digit. Molecular testing of TGFBR2 was
sent to a commercial laboratory and demonstrated a novel, likely pathogenic, variant in exon 4, c.1061T>C, p.(L354P). Molecular
modeling reveals alteration of local protein structure as a result of this pathogenic variant. This pathogenic variant has not been
previously reported in LDS and thus expands the pathogenic variant spectrum of this condition.
1. Background
Loeys-Dietz syndrome (LDS) is a connective tissue disor-
der characterized by vascular findings of aneurysm and/or
dissection of cerebral, thoracic, or abdominal arteries and
skeletal findings comprising pectus abnormality, scoliosis,
arachnodactyly, hypermobile joints, congenital contractures
of digits, and talipes equinovarus [1, 2]. In addition, craniofa-
cial findings including hypertelorism, bifid uvula, cleft palate,
and craniosynostosis are commonly observed in patients
affected by LDS. Intellect is generally normal and typically
patients develop arterial aneurysms with death resulting
from a ruptured arterial aneurysm occurring in the third
decade of life if left undiagnosed [2, 3]. TGFBR1 and TGFBR2
pathogenic variants were initially shown to cause LDS,
with subsequent pathogenic variants identified in SMAD3,
TGFB2, and TGFB3. We report a case of a novel pathogenic
variant in TGFBR2 and phenotype consistent with LDS [4]
and demonstrate pathogenic effects on the downstream pro-
tein structure based onnovelmolecularmodeling techniques.
2. Presentation
The proband was a 10-year-old presenting to the genetics
clinic with an enlarged aortic root (Z-score 5-6), pectus
excavatum, and congenital contractures of the right 2nd and
3rd digit. His pediatrician originally referred him to a local
cardiologist for a suspected connective tissue disorder. He
was born at term to a 19-year-old G2P2 mother and 31-year-
old father. Birth weight and length were normal; however,
he was noted to have contractures of the right 2nd and 3rd
digit. Other medical history includes a mild restrictive lung
disease that was felt to be secondary to his moderately severe
pectus excavatum. His development had been normal and
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he was in mainstream education. A three-generation family
pedigree did not reveal any consanguinity. Both parents
were unaffected. Physical examination demonstrated head
circumference of 50 cm (50th percentile), height of 150 cm
(84th percentile), weight of 33.2 kg (42nd percentile), arm
span of 156 cm, arm span/height ratio of 1.04, and upper to
lower segment ratio of 0.923. He was normocephalic and
hyperteloric (inner canthal distance 4 cm, >97th percentile;
outer canthal distance 10 cm, >97th percentile; interpupillary
distance 6.5 cm, >97th percentile). He had nasal asymmetry
and a bifid uvula. There were marked pectus excavatum,
mild scoliosis, shoulder hyperextensibility, negative wrist and
thumb sign, no arachnodactyly, pes planus, and thin translu-
cent skin over anterior chest and arms with evidence of easy
bruising. Echocardiogram demonstrated normal valves with
a severely dilated aortic root between 5-6 Z-scores. He was
prescribed losartan 1mg/kg/day managed by a cardiologist.
Molecular testing of a gene panel including TGFBR1,
TGFBR2, SMAD3, TGFB2, and TGFB3 was performed using
standard techniques via CLIA/CAP certified commercial lab-
oratory and demonstrated a novel likely pathogenic variant
in exon 4 of TGFBR2, denoted by c.1061T>C, p.(L354P). The
variant is in a highly conserved region ofDNA (13/13 species).
The change occurs in the serine-threonine kinase domain of
the protein. Parental testing performed at the same laboratory
revealed this was a de novo change.
Additional findings include pulmonary function tests
confirming a restrictive lung defect, likely related to the
pectus deformity, not reversible by bronchodilators, forwhich
he is followed up by pulmonology. An ophthalmological
exam did not find any evidence of myopia or subluxation.
An MRI/MRA head to pelvis was performed which demon-
strated dolichoectasia of the internal carotid and left vertebral
arteries, tortuosity of vessels within the chest, particularly
vessels arising from the aortic arch, high-grade stenosis at
the origins of the right common carotid and right subclavian
arteries and proximal left common carotid artery, marked
pectus deformity (Haller index of 13.4) causing compression
of the right atrium and leftward shift of heart, and lastly a
mildly tortuous left renal artery. The clinical features found
in our patient were consistent with the diagnosis of LDS.
Interestingly, the patient was followed up by the allergy
clinic for a history of idiopathic urticaria. The patient was
placed on cetirizine and his symptoms resolved. TGFBR
pathogenic variants have been shown to increase the pre-
disposition for allergic disease (including asthma, eczema,
and allergic rhinitis) in patients with LDS because of their
role in directing immune responses to mucosal antigens [5].
A 2013 study suggested that treatment with losartan could
modify allergic disease in patients by reducing excessive
TGFB signaling in lymphocytes [5].
3. Molecular Modeling
We developed a homology-based model for the TGFBR2
kinase domain based on the experimentally solved struc-
ture of Activin Receptor IIA (see Figure 1) using available
structural information for other members of this family
of serine/threonine kinases. Ramachandran plots identified
96.5% of the residues in the allowable regions, reflecting
the high quality of our model. Subsequently, we developed
a model for the L354P variant by in silico site directed
mutagenesis. These models were energy minimized, were
heated to room temperature, and underwent short molecular
dynamics simulation.
Molecular dynamics (MD) simulations were performed
for ourWT and L354P models using the CHARMm all-atom
force-field [6] and a 2 fs time step. A distance-dependent
implicit environment model, as implemented in Discovery
Studio [7], was used with a dielectric constant of 80 and a
pH of 7.4. Each model was energy minimized for 5000 steps
using steepest decent followed by 5000 steps of conjugate
gradient and the SHAKE [8] procedure. Each system was
independently heated to 300K and equilibrated, followed by
generation of 10 ns production simulations. Analyses were
performed in the R programming language [9], leveraging
the bio3d [10] package version 2.2.4. Molecular visualizations
were generated using Discovery Studio and PyMol [11].
These simulations revealed loss of local secondary struc-
ture around L354P as well as resulting shifts in molecular
flexibility. Schematic representation of the protein molecular
model is shown in Figure 1. The L354P variant introduces a
kink within helix E, a secondary structural feature located
underneath the floor of the ATP binding site. We posit that
the L354P pathogenic variant may change the dynamics or
molecular flexibility of the protein, thereby impacting other
key functional regions within the protein.
4. Discussion
LDS is a childhood onset connective tissue disorder char-
acterized by distinctive vascular, anomalies, and molecular
abnormalities. Pathogenic variants in all 5 genes that cause
LDS, TGFBR1, TGFBR2, TGFB2, TGFB3, and SMAD3 result
in loss of wild-type function of the protein product.The novel
pathogenic variant identified in our patient is located in the
intracellular serine-threonine kinase domain, which is where
the majority of pathogenic variants are found. According
to published data, most pathogenic variants in TGFBR2 are
missense, and only a handful of nonsense pathogenic variants
have been reported. It has been reported previously that
the phenotype in LDS results due to excess activation and
signaling by the TGF-𝛽 growth factor [3, 12]. Molecular
confirmation is highlywarranted as it can confirm a diagnosis
suspected on clinical grounds and additionally it is important
to identify the underlying molecular mutation in cases such
as ours as it can be useful to (1) informmanagement, (2) con-
firm the diagnosis, and (3) provide actionable information
for family planning purposes. Additionally, we demonstrate a
novel molecular modeling technique which can be useful for
determining pathogenicity of newly identified variants. This
technique is applicable to many different genes and proteins
and not specific to TGFBR2. In summary, we describe a
patient with LDS and a novel TGFBR2 pathogenic variant,
previously undescribed as causal for LDS, and thus expand
the mutation spectrum of this condition.
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Figure 1: Molecular modeling of the L354P mutation reveals alteration of local structure leading to changes in flexibility. (a) The TGFBR2
kinase domain structure is shown in a blue cartoon representation with amino acid position 354 marked by a red sphere and an adenosine
placed in the ATP binding pocket shown as ball-and-stick. Representatives from the beginning of our MD simulation are shown as white
backbone trace. (b) Root Mean Squared Fluctuations (RMSF) capture the flexibility of the protein and are plotted for the mutant and wt
simulations. Regions with largest difference are highlighted (colored similarly in (a)) and position 354 is marked with an asterisk. (c) During
our simulation, the local helical structure around L354P is destabilized and unwinds, pushing the rest of the helix into an altered conformation.
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